Materialise NV is a provider of 3D-printed medical devices and software and a pioneer in additive manufacturing software and services. The company operates through three principal segments: Materialise Software, Materialise Medical, and Materialise Manufacturing, with the Materialise Medical segment generating maximum revenue. The Materialise Medical segment develops and delivers medical software solutions, medical devices, and related products and services; the Materialise Software segment develops and delivers additive manufacturing software solutions and related services; and the Materialise Manufacturing segment delivers 3D-printed products and related services. The company generates maximum revenue from the United States of America.
Last trade$6.32
Day change+$0.11 (+1.77%)
Day range$6.16 – $6.33
Volume80,223
Market cap$354M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for MTLS.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for MTLS.
Recent news
Company coverage with links to the original publishers.
TCT Asia 2026, the leading additive manufacturing event in Asia-Pacific, has opened free visitor registration for its March 17-19 event in Shanghai. The event will span 55,000+ m² across two halls featuring over 550 exhibitors, including global leaders and Chinese innovators in metal and polymer 3D printing technologies, alongside a revamped conference format with expert sessions and professional certification courses.
The global surgical simulation market is projected to grow at a 15.65% CAGR from 2024 to 2030, reaching $1.14 billion, driven by technological advancements in VR, AI, and haptic feedback that enhance medical training and reduce surgical errors.
Materialise NV, a leading provider of additive manufacturing software and 3D printing solutions, announced that it will host its Annual General Shareholders' Meeting and an Extraordinary Shareholders' Meeting on June 3, 2025.
The polymer additive manufacturing market is expected to grow significantly from 2024 to 2031, driven by cost efficiency, customization, and sustainability benefits. Key growth opportunities include advancements in bioprinting, supply chain resilience, and industry partnerships. North America leads the market due to strong industrial adoption.
The foot orthotic insoles market is expected to grow significantly due to an aging population, increasing prevalence of foot-related ailments, and advancements in manufacturing technology. The demand for custom and prefabricated insoles is booming, driven by consumer recognition of foot wellness and the use of sustainable materials.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.